Our focus is to connect the market potential and opportunity of APAC BioVentures with investors that are interested in opportunities outside of their immediate area. We strive to partner with cutting edge technology and forward-thinking ventures to help pave the way for a better, healthier tomorrow and bring individualized treatments to everyday patients.
- 5 Front Line Investor Partners
- 36 VC Funds in Portfolio
- Focus: PRE-IPO Funding
- Investors focused on: Therapeutic treatments, health tech, gene therapy, orphan drug, stem cell research, cystic fibrosis, Life Sciences
- These investors are focused on helping you develop access to their market
- Act as a bridge between client and investor
- Provide business development consultation, company analysis and strategy, access to diverse network, personalized pitch deck creation, targeted executive summaries, hands on fundraising guidance
We will partner with your company to develop a market strategy and story that will make your company attractive to foreign investors, from there we will introduce you to Venture Capital Funds that we have established are interested in companies from Japan and helping them to enter their local market. We will assist you in preparing and understanding how to appeal to their investment focus. Our aim is for you to secure funding.